APEX-AMI - Pexelizumab in Conjunction With Angioplasty
Latest Information Update: 22 Nov 2023
At a glance
- Drugs Pexelizumab (Primary)
- Indications Myocardial infarction
- Focus Biomarker; Therapeutic Use
- Acronyms APEX-AMI
- Sponsors Procter & Gamble
- 28 Aug 2023 Results comparing 15-year mortality of ST elevation myocardial infarction of Canadian (STEMI) patients with high-risk electrocardiographic findings enrolled within 6 hours of symptom onset undergoing primary PCI, presented at the ESC Congress 2023 - Annual Congress of the European Society of Cardiology
- 09 Nov 2019 Results(n=683) of exploratory analysis assessing associations between SR in ST-segment elevation myocardial infarction (STEMI) using a multimarker cardiovascular proteins strategypublished in the American Heart Journal.
- 13 Feb 2008 Status changed from in progress to completed according to ClinicalTrials.gov.